DBG
NBSE

De Burlo Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

De Burlo Group’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-33
Closed -$32K – 112
2015
Q2 		$32K Sell
33
-370
-92% -$359K 0.01% 104
2015
Q1 		$409K Buy
+403
New +$409K 0.08% 87